Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

LINE-1 Evasion of Epigenetic Repression in Humans.

Sanchez-Luque FJ, Kempen MHC, Gerdes P, Vargas-Landin DB, Richardson SR, Troskie RL, Jesuadian JS, Cheetham SW, Carreira PE, Salvador-Palomeque C, García-Cañadas M, Muñoz-Lopez M, Sanchez L, Lundberg M, Macia A, Heras SR, Brennan PM, Lister R, Garcia-Perez JL, Ewing AD, Faulkner GJ.

Mol Cell. 2019 Jun 20. pii: S1097-2765(19)30396-X. doi: 10.1016/j.molcel.2019.05.024. [Epub ahead of print]

PMID:
31230816
2.

Dynamic Methylation of an L1 Transduction Family during Reprogramming and Neurodifferentiation.

Salvador-Palomeque C, Sanchez-Luque FJ, Fortuna PRJ, Ewing AD, Wolvetang EJ, Richardson SR, Faulkner GJ.

Mol Cell Biol. 2019 Mar 19;39(7). pii: e00499-18. doi: 10.1128/MCB.00499-18. Print 2019 Apr 1.

3.

L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.

Nguyen THM, Carreira PE, Sanchez-Luque FJ, Schauer SN, Fagg AC, Richardson SR, Davies CM, Jesuadian JS, Kempen MHC, Troskie RL, James C, Beaven EA, Wallis TP, Coward JIG, Chetty NP, Crandon AJ, Venter DJ, Armes JE, Perrin LC, Hooper JD, Ewing AD, Upton KR, Faulkner GJ.

Cell Rep. 2018 Jun 26;23(13):3730-3740. doi: 10.1016/j.celrep.2018.05.090.

4.

L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.

Schauer SN, Carreira PE, Shukla R, Gerhardt DJ, Gerdes P, Sanchez-Luque FJ, Nicoli P, Kindlova M, Ghisletti S, Santos AD, Rapoud D, Samuel D, Faivre J, Ewing AD, Richardson SR, Faulkner GJ.

Genome Res. 2018 May;28(5):639-653. doi: 10.1101/gr.226993.117. Epub 2018 Apr 11.

5.

Heritable L1 retrotransposition in the mouse primordial germline and early embryo.

Richardson SR, Gerdes P, Gerhardt DJ, Sanchez-Luque FJ, Bodea GO, Muñoz-Lopez M, Jesuadian JS, Kempen MHC, Carreira PE, Jeddeloh JA, Garcia-Perez JL, Kazazian HH Jr, Ewing AD, Faulkner GJ.

Genome Res. 2017 Aug;27(8):1395-1405. doi: 10.1101/gr.219022.116. Epub 2017 May 8.

6.

Retrotransposon Capture Sequencing (RC-Seq): A Targeted, High-Throughput Approach to Resolve Somatic L1 Retrotransposition in Humans.

Sanchez-Luque FJ, Richardson SR, Faulkner GJ.

Methods Mol Biol. 2016;1400:47-77. doi: 10.1007/978-1-4939-3372-3_4.

PMID:
26895046
7.

Ubiquitous L1 mosaicism in hippocampal neurons.

Upton KR, Gerhardt DJ, Jesuadian JS, Richardson SR, Sánchez-Luque FJ, Bodea GO, Ewing AD, Salvador-Palomeque C, van der Knaap MS, Brennan PM, Vanderver A, Faulkner GJ.

Cell. 2015 Apr 9;161(2):228-39. doi: 10.1016/j.cell.2015.03.026.

8.

Glucose conjugation of anti-HIV-1 oligonucleotides containing unmethylated CpG motifs reduces their immunostimulatory activity.

Reyes-Darias JA, Sánchez-Luque FJ, Morales JC, Pérez-Rentero S, Eritja R, Berzal-Herranz A.

Chembiochem. 2015 Mar 2;16(4):584-91. doi: 10.1002/cbic.201402574. Epub 2015 Feb 11.

PMID:
25683851
9.

Efficient HIV-1 inhibition by a 16 nt-long RNA aptamer designed by combining in vitro selection and in silico optimisation strategies.

Sánchez-Luque FJ, Stich M, Manrubia S, Briones C, Berzal-Herranz A.

Sci Rep. 2014 Sep 1;4:6242. doi: 10.1038/srep06242.

10.

The wide expansion of hepatitis delta virus-like ribozymes throughout trypanosomatid genomes is linked to the spreading of L1Tc/ingi clade mobile elements.

Sánchez-Luque FJ, López MC, Carreira PE, Alonso C, Thomas MC.

BMC Genomics. 2014 May 6;15:340. doi: 10.1186/1471-2164-15-340.

11.

HIV RNA dimerisation interference by antisense oligonucleotides targeted to the 5' UTR structural elements.

Reyes-Darias JA, Sánchez-Luque FJ, Berzal-Herranz A.

Virus Res. 2012 Oct;169(1):63-71. doi: 10.1016/j.virusres.2012.07.004. Epub 2012 Jul 20.

PMID:
22820401
12.

Identification of an hepatitis delta virus-like ribozyme at the mRNA 5'-end of the L1Tc retrotransposon from Trypanosoma cruzi.

Sánchez-Luque FJ, López MC, Macias F, Alonso C, Thomas MC.

Nucleic Acids Res. 2011 Oct;39(18):8065-77. doi: 10.1093/nar/gkr478. Epub 2011 Jun 30.

13.

Inhibition of HIV-1 replication and dimerization interference by dual inhibitory RNAs.

Sánchez-Luque FJ, Reyes-Darias JA, Puerta-Fernández E, Berzal-Herranz A.

Molecules. 2010 Jul 7;15(7):4757-72. doi: 10.3390/molecules15074757.

14.

In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules.

Marton S, Reyes-Darias JA, Sánchez-Luque FJ, Romero-López C, Berzal-Herranz A.

Molecules. 2010 Jun 28;15(7):4610-38. doi: 10.3390/molecules15074610. Review.

15.

Inhibition of HIV-1 replication by RNA-based strategies.

Reyes-Darias JA, Sánchez-Luque FJ, Berzal-Herranz A.

Curr HIV Res. 2008 Nov;6(6):500-14. Review.

16.

Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.

Bartolomé RA, Wright N, Molina-Ortiz I, Sánchez-Luque FJ, Teixidó J.

Cancer Res. 2008 Oct 15;68(20):8221-30. doi: 10.1158/0008-5472.CAN-08-0561.

17.

Inhibition of HIV-1 replication by an improved hairpin ribozyme that includes an RNA decoy.

Barroso-DelJesus A, Puerta-Fernández E, Tapia N, Romero-López C, Sánchez-Luque FJ, Martínez MA, Berzal-Herranz A.

RNA Biol. 2005 Apr;2(2):75-9. Epub 2005 Apr 20.

PMID:
17132944
18.

Targets and tools: recent advances in the development of anti-HCV nucleic acids.

Romero-López C, Sánchez-Luque FJ, Berzal-Herranz A.

Infect Disord Drug Targets. 2006 Jun;6(2):121-45. Review.

PMID:
16789875

Supplemental Content

Loading ...
Support Center